Stockscreener 앱 받기
8.31
8.08%
-0.73
시간 외 거래:
8.43
0.12
+1.44%
전일 마감가:
$9.04
열려 있는:
$8.9
하루 거래량:
4.22M
Relative Volume:
1.71
시가총액:
$1.32B
수익:
$93.95M
순이익/손실:
$-129.87M
주가수익비율:
-9.2333
EPS:
-0.9
순현금흐름:
$-202.88M
1주 성능:
+9.06%
1개월 성능:
+16.22%
6개월 성능:
+2.59%
1년 성능:
-39.91%
1일 변동 폭
$8.20
$9.13
1주일 범위
$7.34
$9.75
52주 변동 폭
$5.28
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
명칭
Wave Life Sciences Ltd
전화
617-949-2900
주소
7 STRAITS VIEW, SINGAPORE
WVE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.31 | 1.44B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-04 | 개시 | Canaccord Genuity | Buy |
| 2025-07-28 | 개시 | Oppenheimer | Outperform |
| 2025-07-16 | 개시 | Citigroup | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Wedbush | Outperform |
| 2025-02-25 | 개시 | Jefferies | Buy |
| 2024-10-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 재개 | JP Morgan | Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-09-09 | 개시 | JP Morgan | Overweight |
| 2024-05-15 | 개시 | Wells Fargo | Overweight |
| 2023-12-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 개시 | Raymond James | Outperform |
| 2023-05-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 개시 | Guggenheim | Buy |
| 2019-07-15 | 개시 | Cowen | Market Perform |
| 2019-04-17 | 재확인 | H.C. Wainwright | Buy |
| 2018-08-07 | 개시 | Stifel | Buy |
| 2018-07-23 | 개시 | H.C. Wainwright | Buy |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2017-02-15 | 개시 | H.C. Wainwright | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-07 | 개시 | Jefferies | Buy |
| 2015-12-07 | 개시 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences (WVE) HD Program Unaffected by uniQure's FDA Hurdles - GuruFocus
Why Wave Life Sciences Ltd. stock appeals to analystsJuly 2025 Review & Low Risk High Win Rate Stock Picks - newser.com
How Wave Life Sciences Ltd. stock compares to market leadersJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com
Can Wave Life Sciences Ltd. recover in the next quarterPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Can Wave Life Sciences Ltd. rally from current levelsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Will Wave Life Sciences Ltd. (1U5) stock hit analyst forecastsJuly 2025 Selloffs & Low Drawdown Investment Strategies - newser.com
Candlestick signals on Wave Life Sciences Ltd. stock todayOil Prices & Daily Momentum Trading Reports - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitorsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturnsLong Setup & Technical Pattern Alert System - newser.com
Can Wave Life Sciences Ltd. stock deliver sustainable ROE2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade
Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
What insider trading reveals about Wave Life Sciences Ltd. stockWall Street Watch & Low Risk High Reward Ideas - newser.com
Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo
Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com
Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena
Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat
Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st
Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN
WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan
Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Nasdaq
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire
Wave Life Sciences (NASDAQ: WVE) posts 85% Activin E drop, 6‑mo durable in INLIGHT - Stock Titan
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire Inc.
Wave Life Sciences Ltd. (WVE) Spotlight on RNA Editing and RNAi: Pipeline and Clinical Advances in Oligonucleotide TherapeuticsSlideshow (NASDAQ:WVE) 2025-10-29 - Seeking Alpha
Wave Life Sciences Reports Positive INLIGHT Trial Results - TipRanks
Wave Life Sciences Ltd Announces Positive Data from INLIGHT Clinical Trial - TradingView
WVE highlights positive target engagement for WVE-007 at Research Day - Stock Titan
Wave Life Sciences Reports Significant Activin E Reductions from WVE-007 in INLIGHT Clinical Trial, Advancing RNA Medicines Pipeline - Quiver Quantitative
Wave Life Sciences Ltd (WVE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Wave Life Sciences Ltd 주식 (WVE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
0.64%
0.35%
자본화:
|
볼륨(24시간):